Newstral
Article
Ccontracostatimes.com on 2015-11-23 23:16
Pfizer-Allergan merger: 10 things to know about corporate inversions
Related news
- 10 things to know about corporate inversionswkrg.com
- Clinton criticizes Pfizer-Allergan merger, calls for inversions crackdownPOLITICO
- New tax-inversion rules kill proposed Allergan-Pfizer merger (+video)heralddemocrat.com
- White House Tax Moves Sink Pfizer-Allergan Mergerbhcourier.com
- Pfizer seen avoiding $48 billion in tax through Allergan mergerSydney Morning Herald
- $160 billion Pfizer-Allergan merger raises outcryThe Fayetteville Observer
- Allergan, Pfizer call off proposed $160B mergerTimesDaily.com
- Pfizer and Allergan agree £106 billion mergerexpressandstar.com
- The Pfizer–Allergan Merger Is a DisgraceThe New Yorker
- Pfizer drops merger with Botox maker Allergan after US tax clampdownexpressandstar.com
- Pfizer and Allergan's $160-billion pharmaceutical merger puts new twist on tax-avoiding inversionsLA Times
- Pfizer, Allergan call off record $160 billion mergerkansascity.com
- Allergan-Pfizer deal could be the biggest merger this yearLA Times
- Allergan, Pfizer call off $160B merger after Treasury rulingThe Columbian
- Report: Pfizer, Allergan close to $150 billion merger dealwtnh.com
- Drugmakers Pfizer, Allergan reportedly on brink of $150 billion mergertriblive.com